Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial Article

Industry Collaboration International Collaboration

cited authors

  • Gerstein, Hertzel C. C.; Li, Zhuoru; Ramasundarahettige, Chinthanie; Baek, Seungjae; Branch, Kelley R. H.; Del Prato, Stefano; Lam, Carolyn S. P.; Lopes, Renato D.; Pratley, Richard; Rosenstock, Julio; Sattar, Naveed

authors

Publication Date

  • March 28, 2023

webpage

published in

category

keywords

  • diabetes mellitus
  • dose-response relationship
  • efpeglenatide
  • glucagon-like peptide-1 receptor
  • immunologic

start page

  • 1004

end page

  • 1013

volume

  • 147

issue

  • 13